1654P TAMARACK: Randomized Phase II trial of the B7-H3 targeting antibody drug conjugate (ADC) vobramitamab duocarmazine (vobra duo) in metastatic castration-resistant prostate cancer (mCRPC).

Autor:	de Bono, J.S.1 (AUTHOR), Helissey, C.2 (AUTHOR), Fizazi, K.3 (AUTHOR), Maroto Rey, J.P.4 (AUTHOR), Roubaud, G.5 (AUTHOR), Antonarakis, E.S.6 (AUTHOR), Sandhu, S.K.7 (AUTHOR), Shore, N.D.8 (AUTHOR), Ratta, R.9 (AUTHOR), Perez Valderrama, B.10 (AUTHOR), Vulsteke, C.11 (AUTHOR), Schafer, L.12 (AUTHOR), Marr, G.13 (AUTHOR), Zhao, E.14 (AUTHOR), Ward, A.F.12 (AUTHOR), Piulats Rodriguez, J.M.15 (AUTHOR)
Zdroj:	Annals of Oncology. 2024 Supplement 2, Vol. 35, pS996-S997. 2p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu